Description:
Diclofenac Sodium 50 mg is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, inflammation, and swelling. It is commonly prescribed for conditions such as arthritis, muscle pain, and post-operative pain.
Prescription:
Yes – Diclofenac Sodium 50 mg typically requires a doctor’s prescription.
Therapeutic Category:
Nonsteroidal Anti-inflammatory Drug (NSAID)
Active Ingredients/Composition:
- Diclofenac Sodium 50 mg per tablet
Vitamins:
Minerals:
Variant:
- Typically available in tablets, delayed-release tablets, and extended-release tablets
- May also be found in gel, injection, or suppository forms under the same active ingredient
Consume Type:
- Oral (for the 50 mg tablet form)
- Directions/Usage:
- Take with food or milk to reduce stomach upset.
- Dosage and duration depend on the medical condition and response to treatment.
- Typically 1 tablet 2 to 3 times daily, as prescribed by a healthcare provider.
Common Side Effects:
- Nausea
- Headache
- Dizziness
- Stomach pain
- Indigestion
- Diarrhea
- Rash
Package Type:
- Usually packaged in blister packs or bottle containers of 10, 20, or 30 tablets
Storage Advice:
- Store at room temperature (15°C to 30°C).
- Keep away from moisture, heat, and direct sunlight.
- Keep out of reach of children.
Safety Advice:
- Avoid alcohol as it increases the risk of stomach bleeding.
- Not recommended in pregnancy (especially third trimester) unless clearly needed.
- Use with caution in patients with kidney, liver, or heart problems.
- Should not be used with other NSAIDs (e.g., ibuprofen, aspirin).
- Not for long-term use unless under medical supervision.
Product Substitutes:
(Some common substitutes with the same active ingredient and dosage)
- Voveran 50
- Voltaren 50
- Diclowin 50
- Diclomol 50
- Diklofen 50
Manufacturer/Marketer:
- Many pharmaceutical companies manufacture Diclofenac Sodium 50 mg, including:
- Novartis (Voltaren)
- Sun Pharmaceutical
- Cipla
- Dr. Reddy’s Laboratories
- Zydus Cadila
Country of Origin:
- Varies by manufacturer; however, originally developed and marketed in Switzerland by Ciba-Geigy (now part of Novartis).
Reviews
There are no reviews yet.